Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 8 of 8 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Betamethasone (D00244) | 1件: Betamethasone Betamethasone | 1件: Betamethasone
Betamethasone
(D00244) 💬1. Betamethasone
| 1件: NR3C1 NR3C1 💬1. Betamethasone
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 8件: 2 2, 28, 46, 65, 83, 90, 96, 235 💬
| ||||||||||||||
| 2 | BETAMETHASONE ACIBUTATE (D00244) | 1件: Betamethasone Betamethasone | 1件: Betamethasone
Betamethasone
(D00244) 💬2. BETAMETHASONE ACIBUTATE
| 1件: NR3C1 NR3C1 💬2. BETAMETHASONE ACIBUTATE
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬2. BETAMETHASONE ACIBUTATE
| ||||||||||||||
| 3 | Betamethasone Oral Solution Period 1 and Period 2 (D00244) | 1件: Betamethasone Betamethasone | 1件: Betamethasone
Betamethasone
(D00244) 💬3. Betamethasone Oral Solution Period 1 and Period 2
| 1件: NR3C1 NR3C1 💬3. Betamethasone Oral Solution Period 1 and Period 2
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 💬3. Betamethasone Oral Solution Period 1 and Period 2
| ||||||||||||||
| 4 | Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days (D00244) Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for ... | 3件: Acetate Acetate,Betamethasone, Phosphate ion | 1件: Betamethasone
Betamethasone
(D00244) 💬4. Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days
| 1件: NR3C1 NR3C1 💬4. Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 2 2 💬4. Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days
| ||||||||||||||
| 5 | Betamethasone solution as intramuscular injection Period 1 and Period 2 (D00244) | 1件: Betamethasone Betamethasone | 1件: Betamethasone
Betamethasone
(D00244) 💬5. Betamethasone solution as intramuscular injection Period 1 and Period 2
| 1件: NR3C1 NR3C1 💬5. Betamethasone solution as intramuscular injection Period 1 and Period 2
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 💬5. Betamethasone solution as intramuscular injection Period 1 and Period 2
| ||||||||||||||
| 6 | Intra-articular Compound Betamethasone (D00244) | 1件: Betamethasone Betamethasone | 1件: Betamethasone
Betamethasone
(D00244) 💬6. Intra-articular Compound Betamethasone
| 1件: NR3C1 NR3C1 💬6. Intra-articular Compound Betamethasone
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬6. Intra-articular Compound Betamethasone
| ||||||||||||||
| 7 | Intraarticular betamethasone (D00244) | 1件: Betamethasone Betamethasone | 1件: Betamethasone
Betamethasone
(D00244) 💬7. Intraarticular betamethasone
| 1件: NR3C1 NR3C1 💬7. Intraarticular betamethasone
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬7. Intraarticular betamethasone
| ||||||||||||||
| 8 | Phosphate and betamethasone acetate, 2 mL. (D00244) | 3件: Acetate Acetate,Betamethasone, Phosphate ion | 1件: Betamethasone
Betamethasone
(D00244) 💬8. Phosphate and betamethasone acetate, 2 mL.
| 1件: NR3C1 NR3C1 💬8. Phosphate and betamethasone acetate, 2 mL.
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 235 235 💬8. Phosphate and betamethasone acetate, 2 mL.
|